GlassScriptPhysician profile
Zenobia E Ofori-Dankwa
NPI 1942869052
$2,697.88
in general payments reported to CMS, 2019-2025
9 companies · $2,158 in 2025
The $2,158 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.98 · 2022: $59.39 · 2023: $118 · 2024: $332 · 2025: $2,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Food and Beverage | $607.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,100.36 | 2022-2025 | |
| Hologic Sales and Service, LLC | $135.61 | 2024 | Aptima |
| Lilly USA, LLC | $123.08 | 2024 | Taltz |
| Northgate Technologies, INC. | $117.98 | 2023 | Nti Branded Other (Nti) |
| Karl Storz Endoscopy-America | $99.92 | 2025 | Na |
| Smith+Nephew, INC. | $48.31 | 2024 | Stravix |
| Amag Pharmaceuticals, INC. | $30.98 | 2019 | |
| Medical Device Business Services, INC. | $24.65 | 2024 | Enseal |
| Abbvie INC. | $16.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zenobia Ofori-Dankwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.